相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。p70 S6 Kinase and Tau in Alzheimer's Disease
Jin-Jing Pei et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story
Arlan Richardson et al.
EXPERIMENTAL GERONTOLOGY (2015)
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease
Antonella Caccamo et al.
JOURNAL OF NEUROSCIENCE (2015)
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature
Antonella Caccamo et al.
JOURNAL OF NEUROSCIENCE (2014)
Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease
Liang Hong et al.
NEUROLOGICAL RESEARCH (2014)
The role of protein clearance mechanisms in organismal ageing and age-related diseases
David Vilchez et al.
NATURE COMMUNICATIONS (2014)
Over-expression of PRAS40 enhances insulin sensitivity in skeletal muscle
Claudia Wiza et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2014)
Knockdown of PRAS40 inhibits insulin action via proteasome-mediated degradation of IRS1 in primary human skeletal muscle cells
C. Wiza et al.
DIABETOLOGIA (2013)
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson et al.
NATURE (2013)
Use of an Eight-arm Radial Water Maze to Assess Working and Reference Memory Following Neonatal Brain Injury
Stephanie C. Penley et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease
Sharon C Yates et al.
Acta Neuropathologica Communications (2013)
Proline-rich Akt substrate of 40 kDa (PRAS40): A novel downstream target of PI3k/Akt signaling pathway
Haitao Wang et al.
CELLULAR SIGNALLING (2012)
Everolimus-induced Lymphedema in a Renal Transplant Recipient: A Case Report
Alparslan Ersoy et al.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION (2012)
Lymphedema of the Breast as a Symptom of Internal Diseases or Side Effect of mTor Inhibitors
U. Hille et al.
LYMPHATIC RESEARCH AND BIOLOGY (2012)
Interaction of fast and slow dynamics in endocrine control systems with an application to β-cell dynamics
Yi-Fang Wang et al.
MATHEMATICAL BIOSCIENCES (2012)
Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review
Christine B. Boers-Doets et al.
ONCOLOGIST (2012)
Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity
David X. Medina et al.
BRAIN PATHOLOGY (2011)
Activation of a non-genomic Pim-1/Bad-Pser75 module is required for an efficient pro-survival effect of Bcl-xL induced by androgen in LNCaP cells
Jaspal Kaur Kumar et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Naturally Secreted Amyloid-β Increases Mammalian Target of Rapamycin (mTOR) Activity via a PRAS40-mediated Mechanism
Antonella Caccamo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits
Smita Majumder et al.
PLOS ONE (2011)
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS
Antonella Caccamo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PRAS40 Acts as a Nodal Regulator of High Glucose-Induced TORC1 Activation in Glomerular Mesangial Cell Hypertrophy
Nirmalya Dey et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-beta Levels in a Mouse Model of Alzheimer's Disease
Patricia Spilman et al.
PLOS ONE (2010)
PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells
Fengxue Zhang et al.
CANCER BIOLOGY & THERAPY (2009)
The Sun Health Research Institute Brain Donation Program: Description and experience, 1987-2007
Thomas G. Beach et al.
CELL AND TISSUE BANKING (2008)
The ubiquitin-proteasome system in Alzheimer's disease
Salvatore Oddo
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Aβ inhibits the proteasome and enhances amyloid and tau accumulation
Bertrand P. Tseng et al.
NEUROBIOLOGY OF AGING (2008)
PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding
Lifu Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Yasemin Sancak et al.
MOLECULAR CELL (2007)
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Emilie Vander Haar et al.
NATURE CELL BIOLOGY (2007)
Insulin-mediated phosphorylation of the proline-rich Akt substrate PRAS40 is impaired in insulin target tissues of high-fat diet-fed rats
Emmani B. M. Nascimento et al.
DIABETES (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice
Jennifer Alamed et al.
NATURE PROTOCOLS (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002
MD Jacobs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease
L Lovasic et al.
GENES BRAIN AND BEHAVIOR (2005)
Alzheimer's disease:: Aβ, tau and synaptic dysfunction
FM LaFerla et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Methods for monitoring autophagy
N Mizushima
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders
R Layfield et al.
AGEING RESEARCH REVIEWS (2003)
Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease
WL An et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimer's disease
RCC Chang et al.
NEUROREPORT (2002)
Impaired proteasome function in Alzheimer's disease
JN Keller et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
